Search by keywords: Connect with us Sloan Kettering @GSKGradSchool 521 News Items found In the Lab “Molecular Origami” Enables Proteins to Serve as Specialized Delivery Vehicles, Study Finds Monday, August 12, 2019 Scientists at the Sloan Kettering Institute have identified a fundamentally new type of protein-sorting system in cells. In the Lab Analyzing Urine Can Guide the Treatment of Childhood Kidney Tumors Thursday, August 8, 2019 A protein detected in the urine of children with Wilms’ tumor led to the development of a test to improve diagnosis and treatment. Finding Sugar Directly Controls a Cancer-Causing Protein, Scientists Find Thursday, August 8, 2019 The discovery suggests a potential new treatment approach for certain cancers. Finding Whether a BRCA Mutation Leads to Cancer Depends on Context, Study Finds Wednesday, July 10, 2019 Sometimes a BRCA mutation is just along for the ride, rather than driving a tumor’s development. In the Lab Drug That Hits CAR T Snooze Button Can Quiet a Cytokine Storm Wednesday, July 3, 2019 An FDA-approved drug used to treat leukemia can serve as a temporary off switch for CAR T cells, MSK scientists have found. In the Lab Scientists Use CRISPR to Learn How Cells Make Decisions Tuesday, July 2, 2019 The genome-editing technique uncovered several genes previously not known to influence embryonic development. In the Lab Research Clarifies How IDH Mutations Cause Cancer Monday, July 1, 2019 The MSK team’s goal was to get at the underlying defects in cells that these mutations cause. Announcement GSK Students Win Grants to Fund Innovative Cancer Research Friday, June 28, 2019 Two outstanding graduate students from the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences (GSK) have been awarded federal funding to pursue promising cancer research. In the Lab Stem Cells Stay “Young” on a Fat-Free Diet Thursday, June 27, 2019 Researchers have discovered a simple way to keep stem cells in a more flexible state for research and potential treatments. In the Lab Researchers Unravel the Biology of a Distinct Prostate Cancer Subtype Wednesday, June 26, 2019 Mutations in a gene called FOXA1 are responsible for a distinct class of prostate cancer tumors, MSK researchers have found. Pagination Load More